Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis.

about

Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis.

Item

http://www.wikidata.org/entity/Q40139987

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Adverse Effects and Choice bet ...... tidrug-Resistant Tuberculosis.

@en

type

Item

label

Adverse Effects and Choice bet ...... tidrug-Resistant Tuberculosis.

@en

prefLabel

Adverse Effects and Choice bet ...... tidrug-Resistant Tuberculosis.

@en

P1476

Adverse Effects and Choice bet ...... tidrug-Resistant Tuberculosis.

@en

P2093

Amber Arnold

http://www.w3.org/2001/XMLSchema#string

Angela Loyse

http://www.w3.org/2001/XMLSchema#string

Graham S Cooke

http://www.w3.org/2001/XMLSchema#string

Marc Lipman

http://www.w3.org/2001/XMLSchema#string

Martin Dedicoat

http://www.w3.org/2001/XMLSchema#string

Onn Min Kon

http://www.w3.org/2001/XMLSchema#string

P2860

Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort

Capreomycin-induced serum electrolyte abnormalities

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa

Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.

Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.

A molecular basis for human hypersensitivity to aminoglycoside antibiotics.

Adverse Events Associated With the Treatment of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis.

P31

scholarly article

P356

10.1128/AAC.02586-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Irina Chis Ster

Thomas Harrison

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28696239

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

5571306

http://www.w3.org/2001/XMLSchema#string